Sharmila Jandial

Newcastle Upon Tyne, ENG, GB 
Newcastle Upon Tyne, ENG, GB 

Overview

Sharmila Jandial practices practicing medicine in Newcastle Upon Tyne, United Kingdom.

Her clinical expertise encompasses Uveitis and Juvenile Idiopathic Arthritis (JIA).

She is actively involved in clinical research, co-authoring 15 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Newcastle Upon Tyne, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open-label, Active-Controlled, Safety, and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
An Open-label, Active-Controlled, Safety, and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
Enrollment Status: Active_not_recruiting
Publish Date: April 24, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, Adalimumab
Study Phase: Phase 3
Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial
Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial
Enrollment Status: Completed
Publish Date: May 11, 2025
Intervention Type: Other, Biological
Study Drug: Adalimumab
Study Phase: Phase 4
View 1 Less Clinical Trial

15 Total Publications

The development of pGALSplus: evaluating feasibility and acceptability of an assessment to facilitate the identification and triage of children with musculoskeletal presentations.
The development of pGALSplus: evaluating feasibility and acceptability of an assessment to facilitate the identification and triage of children with musculoskeletal presentations.
Journal: Rheumatology advances in practice
Published: March 05, 2024

Frequently Asked Questions about Sharmila Jandial

Is Sharmila Jandial a top-rated expert for Uveitis?

MediFind is an objective health platform that identifies experts based on real-world data. Sharmila Jandial is classified as an Experienced expert for Uveitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sharmila Jandial participate in research or clinical trials?

Yes. Sharmila Jandial has published 15 articles and abstracts on conditions like Uveitis. You can view a list of Sharmila Jandial's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Jandial's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile